Elanco Animal Health Inc

NYSE: ELAT · Real-Time Price · USD
21.32
0.22 (1.04%)
At close: Jan 31, 2023, 10:00 PM

Elanco Animal Health Inc Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
4.44B 4.42B 4.42B 4.76B
Cost of Revenue
2.53B 2.48B 1.91B 2.13B
Gross Profit
1.91B 1.94B 2.5B 2.63B
Operating Income
251M 326M 175M -331M
Interest Income
n/a n/a n/a n/a
Pretax Income
488M -1.2B -66M -567M
Net Income
338M -1.23B -74M -472M
Selling & General & Admin
1.31B 1.28B 1.27B 1.4B
Research & Development
344M 327M 321M 369M
Other Expenses
n/a n/a 528M 556M
Operating Expenses
1.66B 1.61B 2.12B 2.33B
Interest Expense
235M 277M 241M 236M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
4.19B 4.09B 4.03B 4.46B
Income Tax Expense
150M 36M 8M -95M
Shares Outstanding (Basic)
494M 492.3M 488.3M 492M
Shares Outstanding (Diluted)
497.3M 492.3M 488.3M 492M
EPS (Basic)
0.68 -2.5 -0.15 -0.96
EPS (Diluted)
0.68 -2.5 -0.15 -0.96
EBITDA
251M 326M 703M 385M
EBIT
n/a -918M 175M -964M
Depreciation & Amortization
n/a 694M 528M 716M